Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001091568 | SCV001247693 | pathogenic | not provided | 2019-07-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001386317 | SCV001586505 | pathogenic | Familial focal epilepsy with variable foci | 2023-02-10 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Arg78Glyfs*2) in the DEPDC5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DEPDC5 are known to be pathogenic (PMID: 23542697, 23542701). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with nocturnal frontal lobe epilepsy or familial focal epilepsy with variable foci (PMID: 30093711). ClinVar contains an entry for this variant (Variation ID: 871543). |
Equipe Genetique des Anomalies du Developpement, |
RCV001526550 | SCV001736975 | likely pathogenic | Seizure | criteria provided, single submitter | research |